ProCE Banner Activity

What’s Next in LA ART: Lenacapavir

Clinical Thought
In this commentary, I share my thoughts on a new option emerging in the realm of long-acting HIV care with potential application to a range of treatment and prevention settings.

Released: December 19, 2022

Expiration: December 18, 2023

No longer available for credit.

Share

Faculty

Babafemi Taiwo

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

Provided by Clinical Care Options, LLC.
ProCE Banner

Supporters

ViiV Healthcare

Faculty Disclosure

Primary Author

Babafemi Taiwo, MBBS

Assistant Professor
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Babafemi Taiwo, MBBS: consultant/advisor/speaker: Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, ViiV Healthcare.